感染威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 感染威廉亚洲博彩公司

抗菌药物药代动力学/药效学理论临床应用专家共识

2018-06-20 中国医药教育协会感染疾病专业委员会 中化结核和呼吸杂志.2018,41(6):409-446.

抗菌药物药代动力学药效学临床应用

在目前细菌耐药迅速变迁、新抗菌药物研发严重滞后的情况下，药代动力学/药效学（PK/PD）理论的临床应用是发挥现有抗菌药物治疗潜力的可靠策略之一，务必给予足够的重视。近年来关于抗菌药物PK/PD的研究进展迅速，研究发现重症感染患者与健康人的PK/PD数据明显不同，为此国外相关威廉亚洲博彩公司 做出了相应修改感染性疾病的诊治需要多学科的协作，临床医师需要掌握足够的临床药理学知识指导临床治疗，但目前我国尚缺少完整统一

中文标题：

抗菌药物药代动力学/药效学理论临床应用专家共识

发布机构：

中国医药教育协会感染疾病专业委员会

发布日期：

2018-06-20

简要介绍：

在目前细菌耐药迅速变迁、新抗菌药物研发严重滞后的情况下，药代动力学/药效学（PK/PD）理论的临床应用是发挥现有抗菌药物治疗潜力的可靠策略之一，务必给予足够的重视。近年来关于抗菌药物PK/PD的研究进展迅速，研究发现重症感染患者与健康人的PK/PD数据明显不同，为此国外相关威廉亚洲博彩公司 做出了相应修改感染性疾病的诊治需要多学科的协作，临床医师需要掌握足够的临床药理学知识指导临床治疗，但目前我国尚缺少完整统一的关于抗菌药物PK/PD的专家共识。 

拓展威廉亚洲博彩公司 ：与抗菌相关威廉亚洲博彩公司 ：

相关资料下载：
[AttachmentFileName(sort=100, fileName=抗菌药物药代动力学/药效学理论临床应用专家共识)] GetToolGuiderByIdResponse(projectId=1, id=b359f1c001606872, title=抗菌药物药代动力学/药效学理论临床应用专家共识, enTitle=, guiderFrom=中化结核和呼吸杂志.2018,41(6):409-446., authorId=null, author=, summary=在目前细菌耐药迅速变迁、新抗菌药物研发严重滞后的情况下，药代动力学/药效学（PK/PD）理论的临床应用是发挥现有抗菌药物治疗潜力的可靠策略之一，务必给予足够的重视。近年来关于抗菌药物PK/PD的研究进展迅速，研究发现重症感染患者与健康人的PK/PD数据明显不同，为此国外相关威廉亚洲博彩公司 做出了相应修改感染性疾病的诊治需要多学科的协作，临床医师需要掌握足够的临床药理学知识指导临床治疗，但目前我国尚缺少完整统一, cover=, journalId=null, articlesId=null, associationId=1353, associationName=中国医药教育协会感染疾病专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed Jun 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>在目前细菌耐药迅速变迁、新抗菌药物研发严重滞后的情况下，药代动力学/药效学（PK/PD）理论的临床应用是发挥现有抗菌药物治疗潜力的可靠策略之一，务必给予足够的重视。近年来关于抗菌药物PK/PD的研究进展迅速，研究发现重症感染患者与健康人的PK/PD数据明显不同，为此国外相关威廉亚洲博彩公司 做出了相应修改感染性疾病的诊治需要多学科的协作，临床医师需要掌握足够的临床药理学知识指导临床治疗，但目前我国尚缺少完整统一的关于抗菌药物PK/PD的专家共识。 </div> <div><br> </div> 拓展威廉亚洲博彩公司 ：<strong>与<font color=red>抗菌</font>相关威廉亚洲博彩公司 ：</strong><br><ul><li><a href="//www.nyrain.com/guideline/show_article.do?id=f1e8b1c0015a3264" title="《创伤后抗菌药物预防使用专家共识》解读" target=_blank>《创伤后抗菌药物预防使用专家共识》解读</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=29b5a1c00153e98c" title="氟喹诺酮类抗菌药物在儿童应用中的专家共识" target=_blank>氟喹诺酮类抗菌药物在儿童应用中的专家共识</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=65d301c001383136" title="广泛耐药革兰阴性菌感染的实验诊断、抗菌治疗及医院感染控制：中国专家共识" target=_blank>广泛耐药革兰阴性菌感染的实验诊断、抗菌治疗及医院感染控制：中国专家共识</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=a51561c00135e81f" title="抗菌药物超说明书用法专家共识" target=_blank>抗菌药物超说明书用法专家共识</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=c1e731c001355559" title="2017 NICE威廉亚洲博彩公司 ：抗菌药物管理（NG.63）" target=_blank>2017 NICE威廉亚洲博彩公司 ：抗菌药物管理（NG.63）</a></li> 更多信息请点击：<a href="//www.nyrain.com/guideline/list.do?q=%E6%8A%97%E8%8F%8C" target=_blank>有关抗菌更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=5642, tagName=抗菌药物), TagDto(tagId=17730, tagName=药代动力学), TagDto(tagId=27276, tagName=药效学), TagDto(tagId=611, tagName=临床应用)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8665, appHits=508, showAppHits=0, pcHits=5091, showPcHits=4599, likes=122, shares=29, comments=8, approvalStatus=1, publishedTime=Sun Jun 24 23:12:46 CST 2018, publishedTimeString=2018-06-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 24 23:12:46 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:38:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=抗菌药物药代动力学/药效学理论临床应用专家共识)])
抗菌药物药代动力学/药效学理论临床应用专家共识
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=349621, encodeId=ca643496215f, content=学习了，非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Wed Oct 17 08:50:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327930, encodeId=e4ff32e93054, content=好东西!很多很好!值得好好研究!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Fri Jun 29 09:27:22 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326866, encodeId=bf3332686630, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:41:46 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326772, encodeId=5a83326e7285, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 01:00:55 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326764, encodeId=9705326e645b, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Jun 25 00:30:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-10-17 foxv3羽翼

    学习了，非常有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=349621, encodeId=ca643496215f, content=学习了，非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Wed Oct 17 08:50:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327930, encodeId=e4ff32e93054, content=好东西!很多很好!值得好好研究!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Fri Jun 29 09:27:22 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326866, encodeId=bf3332686630, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:41:46 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326772, encodeId=5a83326e7285, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 01:00:55 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326764, encodeId=9705326e645b, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Jun 25 00:30:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-29 小不忍则

    好东西!很多很好!值得好好研究!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=349621, encodeId=ca643496215f, content=学习了，非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Wed Oct 17 08:50:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327930, encodeId=e4ff32e93054, content=好东西!很多很好!值得好好研究!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Fri Jun 29 09:27:22 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326866, encodeId=bf3332686630, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:41:46 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326772, encodeId=5a83326e7285, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 01:00:55 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326764, encodeId=9705326e645b, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Jun 25 00:30:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 139****5926

    好好文章学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=349621, encodeId=ca643496215f, content=学习了，非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Wed Oct 17 08:50:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327930, encodeId=e4ff32e93054, content=好东西!很多很好!值得好好研究!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Fri Jun 29 09:27:22 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326866, encodeId=bf3332686630, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:41:46 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326772, encodeId=5a83326e7285, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 01:00:55 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326764, encodeId=9705326e645b, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Jun 25 00:30:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 phoebeyan520

    学习了.谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=349621, encodeId=ca643496215f, content=学习了，非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Wed Oct 17 08:50:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327930, encodeId=e4ff32e93054, content=好东西!很多很好!值得好好研究!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Fri Jun 29 09:27:22 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326866, encodeId=bf3332686630, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:41:46 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326772, encodeId=5a83326e7285, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 01:00:55 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326764, encodeId=9705326e645b, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Jun 25 00:30:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 飛歌

    学习了很有用

    0

相关威廉亚洲博彩公司

《创伤后抗菌药物预防使用专家共识》解读

暂未更新 · 2017-12-30

2015 NICE威廉亚洲博彩公司 ：抗菌药物管理（NG.15）

暂未更新 · 2015-08-18

2016 BSAC/EWMA意见书：创伤护理中抗菌药物管理

英国抗菌化疗学会(BSAC,British Society for Antimicrobial Chemotherapy) · 2016-07-25